Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!




January 23 - 25 2015, 12:00 AM - 12:00 AM


February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit



December 18, 2014

0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter


FDA MedWatch Recall - Particulate Matter

November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur


FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled


Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled



Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

ASA Addresses Key Findings and Recommendations of IOM Pain Report to Senate HELP Committee

Wednesday, February 29, 2012

ASA addressed the key findings and recommendations from the Institute of Medicine's (IOM) report, Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research, in an official Statement for the Record to the U.S. Senate Committee on Health, Education, Labor & Pensions (HELP). The February 14 hearing entitled, Pain in America: Exploring Challenges to Relief, largely focused on the June 2011 IOM report. The IOM report assessed the current state of the science of pain research, care, and education and made numerous recommendations that the authors believe would advance the field of pain medicine. 

In the Statement for the Record, ASA highlighted key findings and recommendations of the IOM report that will help anesthesiologists provide more efficient and effective pain care for their patients. ASA agreed with the IOM report that pain is often a symptom of a disease, but chronic pain can be a disease in itself. Multimodal interventions should be used to care for patients with chronic pain, and when available, multidisciplinary programs should be used.  In addition, ASA was pleased that the IOM report calls for collecting timely and consistent data on pain and expanding pain research. 

ASA, in leading the implementation of the IOM report’s recommendations, is developing additional educational materials for patients that promote and enable self-management of chronic pain to enhance our existing patient-centered offerings.

While the IOM report highlights the need for better pain care, ASA expressed concern that “the IOM report calls into question state laws that restrict the scope of practice of nurses and recommends that educational programs for nursing 'have increased capacity to train providers who can offer advanced pain care' ” (quoting IOM report, pages 204, 210). To ensure patient safety and the highest quality of care, ASA reiterated its position that “interventional pain management is the practice of medicine provided only by qualified MDs/DOs.” 

In regard to public and physician education on chronic pain, ASA urged the Senate HELP Committee to reconsider mandating a public education campaign on pain management and expressed support for the NIH Pain Consortium’s new funding opportunity to create Centers of Excellence in Pain Education at medical, dental, pharmacy, and nursing professional schools. 

Click here to learn more about ASA’s advocacy in Pain Medicine.

Click here to read the official Statement for the Record.

« Back to Washington Alerts